{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:48:40Z","timestamp":1792522120591,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["491454339"],"award-info":[{"award-number":["491454339"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG MU 3629\/6-1"],"award-info":[{"award-number":["DFG MU 3629\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DI 1501\/9"],"award-info":[{"award-number":["DI 1501\/9"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008001","name":"Universit\u00e4t zu K\u00f6ln","doi-asserted-by":"publisher","award":["GR 3932\/2-2"],"award-info":[{"award-number":["GR 3932\/2-2"]}],"id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011566","name":"Marga und Walter Boll-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ekir.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T19:26:37Z","timestamp":1684610797000},"page":"1616-1626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life"],"prefix":"10.1016","volume":"8","author":[{"given":"Polina","family":"Todorova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita","family":"Arjune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Oehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Krau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Burkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker Rolf","family":"Burst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman-Ulrich","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.ekir.2023.05.011_bib1","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.05.011_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2215\/CJN.16871020","article-title":"Overweight and obesity and progression of ADPKD","volume":"16","author":"Nowak","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.05.011_bib3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2023.05.011_bib4","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ckj\/sfy103","article-title":"Management of autosomal-dominant polycystic kidney disease-state-of-the-art","volume":"11","author":"Muller","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2023.05.011_bib5","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2023.05.011_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jcph.880","article-title":"Pharmacokinetics and pharmacodynamics of tolvaptan in autosomal dominant polycystic kidney disease: phase 2 trials for dose selection in the pivotal Phase 3 trial","volume":"57","author":"Shoaf","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ekir.2023.05.011_bib7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2016040448","article-title":"Urine osmolality, response to tolvaptan, and outcome in autosomal dominant polycystic kidney disease: results from the TEMPO 3:4 trial","volume":"28","author":"Devuyst","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.05.011_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/j.ajkd.2018.09.016","article-title":"Determinants of urine volume in ADPKD patients using the vasopressin V2 receptor antagonist tolvaptan","volume":"73","author":"Kramers","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.05.011_bib9","doi-asserted-by":"crossref","unstructured":"Borrego-Utiel F-J, Isabel Morales Garc\u00eda A, Polo Moyano A, et\u00a0al. Identifying the Main Predictors of urine output in autosomal dominant polycystic kidney disease (ADPKD) patients taking tolvaptan. Int Urol Nephrol. Forthcoming\u00a02023.","DOI":"10.1093\/ndt\/gfac061.001"},{"key":"10.1016\/j.ekir.2023.05.011_bib10","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/ckj\/sfac144","article-title":"Flank pain has a significant adverse impact on quality of life in ADPKD: the CYSTic-QoL study","volume":"15","author":"Winterbottom","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2023.05.011_bib11","article-title":"Tolvaptan in ADPKD patients at the University of Padova Nephrology Unit: impact on quality of life, efficacy and safety. Article in Italics","volume":"39","author":"Cirella","year":"2022","journal-title":"G\u00a0Ital Nefrol"},{"key":"10.1016\/j.ekir.2023.05.011_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.xkme.2019.11.008","article-title":"Quality of life in autosomal dominant polycystic kidney disease patients treated with tolvaptan","volume":"2","author":"Anderegg","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2023.05.011_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.05.011_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1985.10","article-title":"A\u00a0method for estimating nitrogen intake of patients with chronic renal failure","volume":"27","author":"Maroni","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.05.011_bib14","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1046\/j.1523-1755.2002.00606.x","article-title":"The precision of estimating protein intake of patients with chronic renal failure","volume":"62","author":"Masud","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.05.011_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A\u00a012-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.ekir.2023.05.011_bib16","author":"Kassambara"},{"key":"10.1016\/j.ekir.2023.05.011_bib18","first-page":"65","article-title":"Sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.ekir.2023.05.011_bib19","first-page":"1","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.ekir.2023.05.011_bib34","first-page":"198","article-title":"SF-36 Fragebogen zum Gesundheitszustand. Das Manual","author":"Morfeld","year":"2011","journal-title":"Hogrefe"},{"key":"10.1016\/j.ekir.2023.05.011_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ekir.2017.07.004","article-title":"Tolerability of aquaretic-related symptoms following tolvaptan for autosomal dominant polycystic kidney disease: results from TEMPO 3:4","volume":"2","author":"Devuyst","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2023.05.011_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfab312","volume":"37","author":"Muller","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.05.011_bib22","article-title":"Urine concentrating capacity, vasopressin and copeptin in ADPKD and IgA nephropathy patients with renal impairment","volume":"12","author":"Valenti","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.ekir.2023.05.011_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000463831","article-title":"Relationship between sodium intake and water intake: the false and the true","volume":"70","author":"Bankir","year":"2017","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.ekir.2023.05.011_bib24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.34067\/KID.0007342020","article-title":"Dose-dependent effect of tolvaptan on renal prognosis in patients with autosomal dominant polycystic kidney disease","volume":"2","author":"Akihisa","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2023.05.011_bib25","doi-asserted-by":"crossref","first-page":"F746","DOI":"10.1152\/ajprenal.00339.2020","article-title":"A\u00a0mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus","volume":"319","author":"Mortensen","year":"2020","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2023.05.011_bib26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.ajkd.2016.07.023","article-title":"Low-osmolar diet and adjusted water intake for vasopressin reduction in autosomal dominant polycystic kidney disease: a pilot randomized controlled trial","volume":"68","author":"Amro","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.05.011_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11255-020-02384-3","article-title":"Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention","volume":"52","author":"Cote","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ekir.2023.05.011_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13293-016-0063-0","article-title":"Key influence of sex on urine volume and osmolality","volume":"7","author":"Perinpam","year":"2016","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.ekir.2023.05.011_bib29","article-title":"Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"9","author":"Naranjo","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2023.05.011_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ekir.2020.03.013","article-title":"A\u00a0randomized trial of modified-release versus immediate-release tolvaptan in ADPKD","volume":"5","author":"Perrone","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2023.05.011_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2215\/CJN.11260821","article-title":"Effects of hydrochlorothiazide and metformin on aquaresis and nephroprotection by a vasopressin V2 receptor antagonist in ADPKD: a randomized crossover trial","volume":"17","author":"Kramers","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.05.011_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.metabol.2018.02.009","article-title":"Metformin increases urinary sodium excretion by reducing phosphorylation of the sodium-chloride cotransporter","volume":"85","author":"Hashimoto","year":"2018","journal-title":"Metab Clin Exp"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923013062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923013062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:44:38Z","timestamp":1762832678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923013062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2468024923013062"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.05.011","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}